News & Updates

A French study presented at EULAR 2024 reveals an association between statin treatment and an increased risk of total joint replacement in individuals with knee and hip osteoarthritis (OA).

Treatment with rituximab (RTX) in patients with moderate-to-severe neuropsychiatric (NP) systemic lupus erythematosus (SLE) appears to result in some improvements and to contribute to the use of a much lower steroid dose at 6 months, suggests a study presented at EULAR 2024.

Use of the selective JAK1 inhibitor SHR0302 significantly improves the clinical signs and symptoms of patients with moderate-to-severe active rheumatoid arthritis (RA) who had shown poor response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), according to a study presented at EULAR 2024.

Lung ultrasound (LUS), a low-cost tool with a high negative predictive value, can be a useful instrument for dismissing the presence of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), suggests a study.

Several symptoms of individuals with fibromyalgia (FM), including fatigue and sleep disturbance, have significant impacts on their daily life, and the prevalence of such symptoms may vary depending on demographic categories and disability status, according to a study.